MED-C has acquired the majority of operating funds needed to launch its first project, a registry based on next generation sequencing (NGS) in lung cancer.

Innovative platform enables code-free development of data-rich mobile apps that, on average, deploy five times faster and at half the cost of custom-coded solutions.

Dr. Ryan brought more than 10 years of business and 30 years of science experience to his position as president and CEO and now Chief Scientific Officer of Nuvilex, Inc.